{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-09",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "68462-405",
      "generic_name": "ASPRIN AND EXTENDED-RELEASE DIPYRIDAMOLE",
      "labeler_name": "Glenmark Pharmaceuticals Inc., USA",
      "brand_name": "ASPRIN AND EXTENDED-RELEASE DIPYRIDAMOLE",
      "active_ingredients": [
        {
          "name": "ASPIRIN",
          "strength": "25 mg/1"
        },
        {
          "name": "DIPYRIDAMOLE",
          "strength": "200 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "68462-405-30",
          "description": "30 CAPSULE in 1 BOTTLE (68462-405-30)",
          "marketing_start_date": "20190524",
          "sample": false
        },
        {
          "package_ndc": "68462-405-60",
          "description": "60 CAPSULE in 1 BOTTLE (68462-405-60)",
          "marketing_start_date": "20190524",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {
        "manufacturer_name": [
          "Glenmark Pharmaceuticals Inc., USA"
        ],
        "rxcui": [
          "259081"
        ],
        "spl_set_id": [
          "467d6ce3-bc05-4aa1-87cc-3214fd628d39"
        ],
        "is_original_packager": [
          true
        ],
        "upc": [
          "0368462405604"
        ],
        "nui": [
          "N0000000160",
          "N0000008836",
          "M0001335",
          "N0000175722",
          "N0000175578",
          "N0000008832"
        ],
        "pharm_class_moa": [
          "Cyclooxygenase Inhibitors [MoA]"
        ],
        "pharm_class_pe": [
          "Decreased Prostaglandin Production [PE]",
          "Decreased Platelet Aggregation [PE]"
        ],
        "pharm_class_cs": [
          "Anti-Inflammatory Agents, Non-Steroidal [CS]"
        ],
        "pharm_class_epc": [
          "Nonsteroidal Anti-inflammatory Drug [EPC]",
          "Platelet Aggregation Inhibitor [EPC]"
        ],
        "unii": [
          "R16CO5Y76E",
          "64ALC7F90C"
        ]
      },
      "marketing_category": "ANDA",
      "dosage_form": "CAPSULE",
      "spl_id": "d202f375-08c4-42da-bd96-2b62d7ebe7e8",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20190524",
      "product_id": "68462-405_d202f375-08c4-42da-bd96-2b62d7ebe7e8",
      "application_number": "ANDA210318",
      "brand_name_base": "ASPRIN AND EXTENDED-RELEASE DIPYRIDAMOLE",
      "pharm_class": [
        "Anti-Inflammatory Agents",
        "Non-Steroidal [CS]",
        "Cyclooxygenase Inhibitors [MoA]",
        "Decreased Platelet Aggregation [PE]",
        "Decreased Platelet Aggregation [PE]",
        "Decreased Prostaglandin Production [PE]",
        "Nonsteroidal Anti-inflammatory Drug [EPC]",
        "Platelet Aggregation Inhibitor [EPC]",
        "Platelet Aggregation Inhibitor [EPC]"
      ]
    }
  ]
}